NCT02613312View on ClinicalTrials.gov

Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

TerminatedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

March 18, 2016

Primary Completion Date

October 5, 2020

Study Completion Date

October 5, 2020

Conditions
MesotheliomaSolitary Fibrous Tumor of the Pleura
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02613312 - Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter